Multimodality MR imaging assessment of myocardial viability: combination of first-pass and late contrast enhancement to wall motion dynamics and comparison with FDG PET-initial experience.
暂无分享,去创建一个
J Knuuti | H J Aronen | L Toivonen | J. Knuuti | H. Aronen | L. Toivonen | K. Lauerma | L. Voipio‐Pulkki | P. Niemi | M. Mäkijärvi | L M Voipio-Pulkki | H. Hänninen | K Lauerma | P Niemi | H Hänninen | T Janatuinen | T Mäkelä | M A Mäkijärvi | T. Janatuinen | T. Mäkelä
[1] E. Atalar,et al. Regional heterogeneity of human myocardial infarcts demonstrated by contrast-enhanced MRI. Potential mechanisms. , 1995, Circulation.
[2] R Härkönen,et al. Myocardial viability: fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization. , 1994, American heart journal.
[3] M A Horsfield,et al. A myocardial perfusion reserve index in humans using first-pass contrast-enhanced magnetic resonance imaging. , 1999, Journal of the American College of Cardiology.
[4] K. Takeda,et al. Assessment of myocardial fibrosis in cardiomyopathic hamsters with gadolinium-DTPA enhanced magnetic resonance imaging. , 1998, Investigative radiology.
[5] F. Epstein,et al. Improved coverage in dynamic contrast‐enhanced cardiac MRI using interleaved gradient‐echo EPI , 1998, Magnetic resonance in medicine.
[6] J. Debatin,et al. Normal myocardial perfwsion assessed with multishot echo‐planar imaging , 1997 .
[7] E. Rostrup,et al. Quantification of gadolinium-DTPA concentrations for different inversion times using an IR-turbo flash pulse sequence: a study on optimizing multislice perfusion imaging. , 1998, Magnetic resonance imaging.
[8] R O Bonow,et al. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction. , 1998, Circulation.
[9] U Sechtem,et al. Gradient-echo magnetic resonance imaging during incremental dobutamine infusion for the localization of coronary artery stenoses. , 1994, European heart journal.
[10] E. Holman,et al. Validation of low-dose dobutamine magnetic resonance imaging for assessment of myocardial viability after infarction by serial imaging. , 1998, The American journal of cardiology.
[11] C. Higgins,et al. Measurement of the distribution volume of gadopentetate dimeglumine at echo-planar MR imaging to quantify myocardial infarction: comparison with 99mTc-DTPA autoradiography in rats. , 1999, Radiology.
[12] D. Longmore,et al. Detection of coronary artery disease using MR imaging with dipyridamole infusion. , 1990, Journal of computer assisted tomography.
[13] A. Roos,et al. Contrast enhanced and functional magnetic resonance imaging for the detection of viable myocardium after infarction. , 1998, American heart journal.
[14] R R Edelman,et al. Contrast-enhanced echo-planar MR imaging of myocardial perfusion: preliminary study in humans. , 1994, Radiology.
[15] D. Pennell,et al. Dipyridamole magnetic resonance imaging: a comparison with thallium-201 emission tomography. , 1990, British heart journal.
[16] A de Roos,et al. MR imaging of acute myocardial infarction: value of Gd-DTPA. , 1988, AJR. American journal of roentgenology.
[17] A E Stillman,et al. Magnetic resonance first‐pass myocardial perfusion imaging: Clinical validation and future applications , 1999, Journal of magnetic resonance imaging : JMRI.
[18] K. Yu,et al. The Use of Contrast-Enhanced Magnetic Resonance Imaging To Define Ischemic Injury after Reperfusion: Comparison in Normal and Hypertrophied Hearts , 1994, Investigative radiology.
[19] E. Erdmann,et al. Comparison of dobutamine transesophageal echocardiography and dobutamine magnetic resonance imaging for detection of residual myocardial viability. , 1996, The American journal of cardiology.
[20] K. Hamacher,et al. Efficient stereospecific synthesis of no-carrier-added 2-[18F]-fluoro-2-deoxy-D-glucose using aminopolyether supported nucleophilic substitution. , 1986, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] P. Hekali,et al. Multislice MRI in assessment of myocardial perfusion in patients with single-vessel proximal left anterior descending coronary artery disease before and after revascularization. , 1997, Circulation.
[22] M. Sprenger,et al. Value of gadolinium-diethylene-triamine pentaacetic acid dynamics in magnetic resonance imaging of acute myocardial infarction with occluded and reperfused coronary arteries after thrombolysis. , 1990, The American journal of cardiology.
[23] C M Kramer,et al. Integrated approach to ischemic heart disease. The one-stop shop. , 1998, Cardiology clinics.
[24] E. Erdmann,et al. Dobutamine magnetic resonance imaging predicts contractile recovery of chronically dysfunctional myocardium after successful revascularization. , 1998, Journal of the American College of Cardiology.
[25] Didier Revel,et al. Influence of bolus volume and dose of gadolinium chelate for first‐pass myocardial perfusion MR imaging studies , 1995, Journal of magnetic resonance imaging : JMRI.
[26] C. Kramer,et al. Early contrast-enhanced MRI predicts late functional recovery after reperfused myocardial infarction. , 1999, Circulation.
[27] O Strohm,et al. Contrast media-enhanced magnetic resonance imaging visualizes myocardial changes in the course of viral myocarditis. , 1998, Circulation.
[28] M. Reiser,et al. Assessment of myocardial perfusion using multisection first-pass MRI and color-coded parameter maps: a comparison to 99mTc Sesta MIBI SPECT and systolic myocardial wall thickening analysis. , 1999, Magnetic resonance imaging.